We identified a novel interstitial deletion that spanned from exons 5 to 10 of KAL1 in two Japanese brothers with X-linked Kallmann syndrome (KS; MIM no. 308700). Both brothers had hypogonadism, unilateral renal agenesis, and disturbance of the sense of smell, but they had no other neurological manifestations, including mental disturbance. Their mother was confirmed to be an asymptomatic carrier, by use of a comparative multiplex polymerase chain reaction (PCR) analysis. The present patients are further examples of patients with KS without mental disturbance caused by a mutation confined to KAL1.
Introduction
Kallmann syndrome (KS; MIM no. 308700) is characterized by hypogonadotropic hypogonadism and disturbance in the sense of smell (hyposmia/anosmia); KS is also often associated with various other symptoms, including mental disturbance. A segregation analysis revealed genetic heterogeneity, with X-linked, autosomal recessive, and autosomal dominant modes of transmission (Georgopoulos et al. 1997) . The KAL1 gene (KAL1: Genbank accession number, M97252), responsible for the X-linked form of KS, was identified on Xp22.3. Here, we describe a Japanese family with KS associated with a novel interstitial deletion in KAL1.
Subjects and methods
Genomic DNAs were prepared from the peripheral blood of the family members and Japanese volunteers by a phenol/ chloroform method. Each of the 14 exons of KAL1 was amplified using polymerase chain reaction (PCR) primers designed according to Hardelin et al. (1992) .
The quantity of KAL1 PCR products was evaluated using NPC1 PCR products as an internal standard. NPC1 (Genbank accession number, AF002020) is a gene responsible for Niemann-Pick disease type C (MIM, 257220) and is located on 18q. The PCR contained 40pmol of each primer (exon 7 of KAL1 and exon 20 of NPC1: 5Ј-GTA ATG CCC CTC ACT GTC AG-3Ј and 5Ј-GTC TTA GCC CAG TCC TCT CC-3Ј), 2.5 nM of dNTPs (Gene Amp dNTPs mix), 100ng of genomic DNA, standard PCR buffer, and 1U of Ampli Taq Gold (Perkin Elmer, Norwalk, CT, USA) in a final volume of 10µl. Cycling conditions were 10 min at 95°C initial denaturation, 20-35 cycles of 30s at 95°C, 30 s at 55°C, and 60 s at 72°C, followed by a final extension for 5min at 72°C. The amplified products were analyzed by electrophoresis on a 6% polyacrylamide gel and with SYBR Green staining (Molecular Probe, Eugene, OR, USA). The intensity of each band was measured using a densitometer (Atto, Tokyo, Japan) and the intensities of KAL1 bands were evaluated as relative to the intensities of NPC1 bands (KAL1/NPC1 ratio). To verify that the obtained ratio reflected the gene dosage in the templates, samples from 10 male and 11 female subjects were also examined.
Results and discussion
The probands were the two male offspring (patient 1, aged 33 years, and patient 2, aged 29 years) of three offspring (the other was a healthy female) of healthy parents. Both brothers had been operated on for cryptorchism and had received gonadotropin replacement therapy since their early teens. Patient 1 had a standard stature with a height of 174 cm (ϩ0.643 SD) and weighted 62 kg (body mass index [BMI] , 20.5); patient 2 had a height of 177 cm (ϩ1.88 SD), weighed 104 kg (BMI, 33.2), and was obviously obese (Fig.  1) . Both patients had a mild eunuchoid appearance and both had unilateral renal aplasia, as revealed by ultrasonography. Both had normal intelligence and neither had any neurological signs. Although neither of the patients had subjective complaints of hyposmia, both were revealed to have a cryptic disturbance of the olfactory sense, by the use of an alinamin infusion test and the T&T olfactometer test. Both of them had low levels of serum testosterone and luteinizing hormone, follicle stimulating hormone (LH, FSH), which did not respond to human chorionic gonadotropin (hCG) and gonadotropin releasing hormone (GnRH) stimulation, respectively.
All of the KAL1 exons were successfully amplified from control genomic DNAs, whereas six exons (exons 5-10) were not amplified from the DNAs of the probands (Fig.  2a) , suggesting the presence of an interstitial deletion that spanned from exon 5 to exon 10 in both patients' DNAs. To confirm the carrier status of their mother, we quantified the gene dosage of KAL1 exon 7 by comparative multiplex (CM)-PCR. This analysis of control male and female DNAs showed that the obtained gene dosage index (KAL1/NPC1 ratio) reflected the expected gene dosage (0.5 for males and 1.0 for females) within a cycle number of up to 23 (Fig. 2b) . Because of deviation of the index from the actual gene dose with cycle numbers more than 23, the cycle was set to 23 in the following experiments. CM-PCR analyses of the mother's DNA under this condition gave a KAL1/NPC1 ratio of 0.45 (mean; n ϭ 5; maximum ratio, 0.49; minimum ratio, 0.40), clearly indicating that she had only one allele of KAL1 exon 7. As expected, the ratio of the probands' DNAs was zero (Fig. 2c) . (Table 1) (Bick et al. 1992; Hardelin et al. 1992; Meindl et al. 1993; Hardelin et al. 1993a,b; Klink et al. 1994; Martul et al. 1995; Parenti et al. 1995; Quinton et al. 1996; Georgopoulos et al. 1997; Gu et al. 1998; O'Neill et al. 1998; Weissörtel et al. 1998; MayaNúñez et al. 1998a,b and Izumi et al. 1999) . Both of the patients described here had hypogonadism and hyposmia (the two hallmarks of KS), but they had no other neurological symptoms. Although a mental or intellectual disturbance was described in the original report of KS (Kallmann et al. 1944) , recent analyses of the genotypephenotype relationship of this syndrome have shown that KS patients with mental disturbance had large deletions on Xp22.3 that extended beyond KAL1 (Table 1 ). In contrast, almost all of the patients with mutations restricted to the KAL1 locus appeared to be free of mental disturbance. Therefore, another gene located close to KAL1 was speculated to be responsible for the mental disturbance (Prager and Braunstein 1993) .
